ElNaggar AC - Search Results

1

Same-day discharge after robotic surgery for endometrial cancer.

Zhang N, Wilson B, Enty MA, Ketch P, Ulm MA, ElNaggar AC, Daily L, Tillmanns T. Zhang N, et al. Among authors: elnaggar ac. J Robot Surg. 2022 Jun;16(3):543-548. doi: 10.1007/s11701-021-01253-0. Epub 2021 Jul 8. J Robot Surg. 2022. PMID: 34236587 Review.

2

Guided outcomes in learned efficiency model in clinical medical education: a randomized controlled trial of self-regulated learning.

Patil AS, Elnaggar AC, Kumar S, Ling FW, Stritter FT, Temiyakarn L, Tillmanns TD. Patil AS, et al. Among authors: elnaggar ac. Am J Obstet Gynecol. 2014 Nov;211(5):544.e1-7. doi: 10.1016/j.ajog.2014.05.048. Epub 2014 Jun 4. Am J Obstet Gynecol. 2014. PMID: 24907703 Clinical Trial.

3

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.

Fuh KC, Secord AA, Bevis KS, Huh W, ElNaggar A, Blansit K, Previs R, Tillmanns T, Kapp DS, Chan JK. Fuh KC, et al. Gynecol Oncol. 2015 Dec;139(3):413-8. doi: 10.1016/j.ygyno.2015.06.041. Epub 2015 Jul 2. Gynecol Oncol. 2015. PMID: 26144600

4

Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort.

Backes FJ, ElNaggar AC, Farrell MR, Brudie LA, Ahmad S, Salani R, Cohn DE, Holloway RW, Fowler JM, O'Malley DM. Backes FJ, et al. Among authors: elnaggar ac. Int J Gynecol Cancer. 2016 Nov;26(9):1717-1721. doi: 10.1097/IGC.0000000000000822. Int J Gynecol Cancer. 2016. PMID: 27575633

5

Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.

Ulm MA, ElNaggar AC, Tillmanns TD. Ulm MA, et al. Among authors: elnaggar ac. Gynecol Oncol. 2018 Oct;151(1):124-128. doi: 10.1016/j.ygyno.2018.08.015. Epub 2018 Aug 16. Gynecol Oncol. 2018. PMID: 30121131 Clinical Trial.

6

Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer.

Ulm MA, Redfern TM, Wilson BR, Ponnusamy S, Asemota S, Blackburn PW, Wang Y, ElNaggar AC, Narayanan R. Ulm MA, et al. Among authors: elnaggar ac. J Pers Med. 2020 Nov 26;10(4):246. doi: 10.3390/jpm10040246. J Pers Med. 2020. PMID: 33256002 Free PMC article.

7

Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report.

ElNaggar A, Zhang N, Scalise CB, Sirard C, Kagey MH, Vaena D, Arend R. ElNaggar A, et al. Gynecol Oncol Rep. 2021 Dec 9;39:100904. doi: 10.1016/j.gore.2021.100904. eCollection 2022 Feb. Gynecol Oncol Rep. 2021. PMID: 35531363 Free PMC article.

8

Radiofrequency and microwave ablation for treatment of recurrent gynecologic malignancies.

Zhang N, Coffman C, Wilson B, Gold J, Baum S, Tillmanns T, ElNaggar A. Zhang N, et al. Int J Gynecol Cancer. 2022 Jun 9:ijgc-2022-003444. doi: 10.1136/ijgc-2022-003444. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35680136

9

Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.

ElNaggar A, Robins D, Baca Y, Arguello D, Ulm M, Arend R, Mantia-Smaldone G, Chu C, Winer I, Holloway R, Krivak T, Jones N, Galvan-Turner V, Herzog TJ, Brown J. ElNaggar A, et al. Gynecol Oncol. 2022 Nov;167(2):306-313. doi: 10.1016/j.ygyno.2022.09.022. Epub 2022 Oct 11. Gynecol Oncol. 2022. PMID: 36229265

10

Risk factors for anal intraepithelial neoplasia in women with genital dysplasia.

ElNaggar AC, Santoso JT. ElNaggar AC, et al. Obstet Gynecol. 2013 Aug;122(2 Pt 1):218-223. doi: 10.1097/AOG.0b013e31829a2ace. Obstet Gynecol. 2013. PMID: 23969787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page